Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1,001 - 10,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 1 epsHosts
Not detected.
Recent guests
Recent episodes
Proteomic Markers of Dietary Patterns and Chronic Kidney Disease
Apr 16, 2026
4m 50s
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
Mar 18, 2026
Unknown duration
Finerenone and eGFR Slope
Feb 26, 2026
Unknown duration
Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure
Feb 18, 2026
Unknown duration
Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients
Dec 18, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/16/26 | Proteomic Markers of Dietary Patterns and Chronic Kidney Disease✨ | dietary patternschronic kidney disease+4 | Dr. Rebholz | American Society of NephrologyProteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study | — | proteomic markersdietary patterns+4 | — | 4m 50s | |
| 3/18/26 |  Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1 | Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1. | — | ||||||
| 2/26/26 | Finerenone and eGFR Slope | Dr. McCausland summarizes the main findings from his study on "Effect of finerenone on eGFR slope across different levels of baseline albuminuria and eGFR: Insights from FINEARTS-HF" on behalf of his coauthors. | — | ||||||
| 2/18/26 | Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure | Dr. Parikh, Dr. Malhotra, and Dr. Thiessen Philbrook summarize the main findings from their study on "Dynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant" on behalf of the authors. | — | ||||||
| 12/18/25 | Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients | Drs. Dagmara Borzych-Dużałka and Khandelval summarize the main findings from their study on "Early-Start vs. Late-Start Icodextrin for Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network". | — | ||||||
| 10/28/25 | Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD | In this podcast, Dr. Sumida summarizes the main findings from his study on "Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD" on behalf of his coauthors. | — | ||||||
| 9/30/25 | SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease | In this podcast, Dr. Neuen summarizes the main findings from his study on "SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials" on behalf of his colleagues. | — | ||||||
| 8/27/25 | Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis | In this podcast, Dr. Ghaddar summarizes the main findings from her study on "Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis" on behalf of her colleagues. | — | ||||||
| 7/25/25 | Perceptions of Future Earnings Among Nephrology Fellows | In this podcast, Drs. Raslan and Triozzi summarize the main findings from their study on "Assessing Current Nephrology Fellows' Perceptions of Future Earnings as Attending Physicians" on behalf of their colleagues. | — | ||||||
| 6/27/25 | SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology | In this podcast, Drs. Eadon, Zhang, and Xu summarize the main findings from their study on "Risk of Urinary Tract Infections with SGLT2 Inhibitors in Subpopulations with Abnormal Genitourinary Pathology" on behalf of their colleagues. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/23/25 | Transition Practices in Pediatric and Adult Nephrology | In this podcast, Dr. Vissing summarizes the main findings from his study on "Bridging the Gap: Assessing Nephrology Transition Practices in Pediatric and Adult Medical Centers" on behalf of his colleagues. | — | ||||||
| 3/25/25 | Creatinine and Cystatin-Based Equations in People with Cancer | In this podcast, Dr. Titan summarizes the main findings from her study on "Performance of creatinine and cystatin-based equations on estimating measured GFR in people with hematological and solid cancers" on behalf of her colleagues. | — | ||||||
| 2/14/25 | GLP1 Receptor Agonists and Kidney Outcomes | In this podcast, Dr. Mendonça summarizes the main findings from his study on "The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials" on behalf of his colleagues. | — | ||||||
| 1/23/25 | Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation | In this podcast, Drs. Khan and Paik summarize the main findings from their study on "Fracture in association with anticoagulant therapy in patients with chronic kidney disease and atrial fibrillation" on behalf of their colleagues. | — | ||||||
| 12/23/24 | Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients | In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues. | — | ||||||
| 11/26/24 | Association of Kidney Function with SGLT2 Inhibitor Discontinuation | In this podcast, Dr. Estrella summarizes the main findings from her study on "Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans" on behalf of her colleagues. | — | ||||||
| 11/15/24 | Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi | In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Qureshi on the findings of his study "The Association of Intra-abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications." | — | ||||||
| 11/14/24 | Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte | In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Limonte on the findings of her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes." | — | ||||||
| 10/21/24 | Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients | In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study" | — | ||||||
| 9/23/24 | Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management | CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD. | — | ||||||
| 8/16/24 | Fellows' Perspectives on Parental Leave Policies and Family Planning | In this podcast, Dr. Kendrick and Dr. Dixon summarize the main findings from their study on "A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship" on behalf of their colleagues. | — | ||||||
| 8/1/24 | Editors' Choice Articles: Pediatric ESKD iron stores, Impact of hemodiafiltration and hemodialysis on β-2-microglobulin, and Novel instruments for dialysis modality awareness | Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument. | — | ||||||
| 12/14/23 | Kidney Measures and Venous Thromboembolism | Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues. | — | ||||||
| 11/20/23 | Participant Experience in the KPMP - Spanish Language | Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish. | — | ||||||
| 11/20/23 | Participant Experience in the KPMP | Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English. | — | ||||||
Showing 25 of 200
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.